Moreover, the endocannabinoids and their receptors (especially cannabinoid 1, CB1) are known to induce steatosis and lipogenic gene expression resulting in NAFLD [86, 87]. This evidence concerns the gene CNR1 and metabolic dysfunction-associated steatotic liver disease.